Jun-Kyu Suh Selected Research

mirodenafil

4/2022	Efficacy and Safety of Mirodenafil Oro-Dispersible Film in Korean Patients with Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Phase IV Study.
9/2010	Efficacy and safety of mirodenafil in men taking antihypertensive medications.
11/2008	Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun-Kyu Suh Research Topics

Disease

40	Erectile Dysfunction 04/2022 - 04/2003
9	Fibrosis (Cirrhosis) 04/2017 - 02/2004
6	Penile Induration (Peyronie's Disease) 08/2021 - 06/2008
5	Ganglion Cysts (Ganglion) 01/2022 - 11/2016
3	Hypoxia (Hypoxemia) 01/2021 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 06/2013
3	Prostatitis 05/2015 - 07/2002
3	Neoplasms (Cancer) 01/2015 - 01/2011
2	Inflammation (Inflammations) 03/2014 - 02/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2013 - 04/2010
2	Hypercholesterolemia 07/2009 - 04/2006
2	Cicatrix (Scar) 06/2008 - 04/2005
2	Type 2 Diabetes Mellitus (MODY) 03/2005 - 04/2003
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020
1	Diabetes Mellitus 01/2019
1	Granuloma 01/2019
1	Bacterial Infections (Bacterial Infection) 05/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Uveitis 02/2014
1	Ischemia 12/2013
1	Vascular Diseases (Vascular Disease) 12/2013
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Wounds and Injuries (Trauma) 09/2012
1	Obesity 11/2010
1	Weight Loss (Weight Reduction) 04/2010
1	Dyslipidemias (Dyslipidemia) 12/2004

Drug/Important Bio-Agent (IBA)

13	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 04/2008
10	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2005
8	Phosphodiesterase 5 InhibitorsIBA 01/2021 - 04/2008
6	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2009 - 02/2004
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2012
4	Streptozocin (Streptozotocin)FDA Link 12/2013 - 04/2003
3	mirodenafilIBA 04/2022 - 11/2008
3	Angiopoietin-1IBA 01/2016 - 04/2006
3	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2015 - 07/2002
3	Messenger RNA (mRNA)IBA 12/2013 - 04/2010
3	CholesterolIBA 12/2013 - 06/2008
2	Therapeutic UsesIBA 01/2021 - 12/2014
2	Small Interfering RNA (siRNA)IBA 01/2019 - 12/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2006
2	CytokinesIBA 05/2015 - 10/2010
2	matrigelIBA 09/2012 - 07/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 10/2008
2	Free RadicalsIBA 03/2005 - 04/2003
1	Lipocalin-2IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 08/2021
1	LM11A-31IBA 01/2021
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2021
1	LigandsIBA 01/2021
1	ParaffinIBA 01/2019
1	Soluble Guanylyl CyclaseIBA 04/2017
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 04/2017
1	rho-Associated KinasesIBA 04/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	Plasminogen Activator Inhibitor 1IBA 01/2016
1	CU06-1004IBA 01/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	Radioisotopes (Radionuclides)IBA 05/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	bcr-abl Fusion ProteinsIBA 01/2015
1	Histone Deacetylase 2IBA 12/2014
1	EndotoxinsIBA 02/2014
1	ethyl 6- (5- (phenylsulfonamido)pyridin- 3- yl)imidazo(1,2- a)pyridine- 3- carboxylateIBA 12/2013
1	imidazopyridineIBA 12/2013
1	ApelinIBA 12/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2013
1	Biological ProductsIBA 01/2013
1	Pulsatilla saponin DIBA 01/2013
1	avanafilIBA 12/2012
1	Erythropoietin FDA Link 09/2012
1	Transcription Factors (Transcription Factor)IBA 05/2011
1	A Kinase Anchor ProteinsIBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	Leptin ReceptorsIBA 11/2010
1	Phosphates (Orthophosphate)IBA 11/2010
1	ResveratrolIBA 04/2010
1	Collagen Type I (Type I Collagen)IBA 04/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2010
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 04/2010
1	Phosphotransferases (Kinase)IBA 05/2009
1	Activin Receptors (Activin Receptor)IBA 05/2009
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 05/2009
1	Transforming Growth Factor-beta Type I ReceptorIBA 05/2009
1	ElastinIBA 06/2008
1	udenafilIBA 04/2008
1	Factor VIII (Coagulation Factor VIII)IBA 10/2007
1	Actins (F Actin)IBA 10/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2005
1	AntioxidantsIBA 03/2005

Therapy/Procedure

8	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 06/2013
7	Therapeutics 04/2017 - 04/2005
4	Intraperitoneal Injections 01/2019 - 04/2003
2	Drug Therapy (Chemotherapy) 12/2019 - 04/2017
2	Injections 01/2019 - 11/2010
1	Oral Administration 01/2021
1	Biological Therapy 04/2017
1	Transplantation 03/2014
1	Aftercare (After-Treatment) 06/2008